Anaemia and MSSA continue to impact outcomes in patients undergoing hip and knee surgeries. A national initiative is currently underway to drive improvement through pre-screening and optimisation of patients. Louise Frampton reports.
A major initiative has been rolled out across 50 Trusts with a view to optimising patients prior to undergoing surgery, in order to improve outcomes and save lives. Building on the successful Quality Improvement for Surgical Teams (QIST) Collaborative model, the project is focusing on the preoperative treatment of mild anaemia and decolonisation of Methicillin Sensitive Staphylococcus aureus (MSSA). Both of these interventions have the potential to have a significant impact
The project, led by Northumbria Healthcare NHS Foundation Trust, in partnership with the British Orthopaedic Association, is backed by an investment of £1.5m – funded by NHS Improvement, the Northumbria NHS Vanguard, and industry (Vifor and Schülke) – with independent evaluation by the University of York Trials Unit.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.